Literature DB >> 24653990

Homozygous factor V Leiden mutation in type IV Ehlers-Danlos patient.

Marwan Refaat1, Mostafa Hotait1, Brion Winston1.   

Abstract

Ehlers-Danlos syndrome (EDS) is a group of inherited connective tissue disorders caused by collagen synthesis defects. Several hemostatic abnormalities have been described in EDS patients that increase the bleeding tendencies of these patients. This case report illustrates a patient with an unusual presentation of a patient with type IV EDS, platelet δ-storage pool disease and factor V Leiden mutation. Young woman having previous bilateral deep vein thrombosis and pulmonary emboli coexisting with ruptured splenic aneurysm and multiple other aneurysms now presented with myocardial infarction. Presence of factor V Leiden mutation raises the possibility that the infarct was due to acute coronary thrombosis, although coronary artery aneurysm and dissection with myocardial infarction is known to occur in vascular type EDS. This is the first report in the medical literature of factor V Leiden mutation in an EDS patient which made the management of our patient challenging with propensity to both bleeding and clotting.

Entities:  

Keywords:  Coagulopathy; Ehlers-Danlos syndrome; Factor V Leiden; Platelets

Year:  2014        PMID: 24653990      PMCID: PMC3955805          DOI: 10.12998/wjcc.v2.i3.75

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  16 in total

1.  Assessment of myocardial perfusion by cardiolite stress testing in a young woman with Ehler-Danlos syndrome and coronary dissection.

Authors:  M E Zied; M N Khalil; M F Wilson
Journal:  Am J Med       Date:  1999-09       Impact factor: 4.965

2.  Acute myocardial infarction in a young female.

Authors:  B H Trichon; J P Zidar; T M Bashore; M Donahue; M H Sketch
Journal:  J Invasive Cardiol       Date:  2001-08       Impact factor: 2.022

Review 3.  Vascular Ehlers-Danlos syndrome: pathophysiology, diagnosis, and prevention and treatment of its complications.

Authors:  Natalia Beridze; William H Frishman
Journal:  Cardiol Rev       Date:  2012 Jan-Feb       Impact factor: 2.644

4.  FUNCTIONAL AND ULTRASTRUCTURAL ABNORMALITIES OF PLATELETS IN EHLERS-DANLOS SYNDROME.

Authors:  H KASHIWAGI; J M RIDDLE; J P ABRAHAM; B FRAME
Journal:  Ann Intern Med       Date:  1965-08       Impact factor: 25.391

5.  Enormous right coronary arterial aneurysm in a patient with type IV Ehlers-Danlos syndrome.

Authors:  U H Eriksen; N A Aunsholt; T T Nielsen
Journal:  Int J Cardiol       Date:  1992-05       Impact factor: 4.164

6.  Coronary aneurysms in a case of Ehlers-Danlos syndrome.

Authors:  C Di Mario; M Zanchetta; P Maiolino
Journal:  Jpn Heart J       Date:  1988-07

7.  Myocardial infarction and coronary artery dissection during pregnancy associated with type IV Ehlers-Danlos syndrome.

Authors:  A M Athanassiou; M A Turrentine
Journal:  Am J Perinatol       Date:  1996-04       Impact factor: 1.862

8.  Platelet and coagulation studies in Ehlers-Danlos syndrome.

Authors:  A Anstey; K Mayne; M Winter; J Van de Pette; F M Pope
Journal:  Br J Dermatol       Date:  1991-08       Impact factor: 9.302

9.  Vascular Ehlers-Danlos syndrome--all three coronary artery spontaneous dissections.

Authors:  Michinari Nakamura; Junji Yajima; Yuji Oikawa; Ken Ogasawara; Tokuhisa Uejima; Keiko Abe; Tadanori Aizawa
Journal:  J Cardiol       Date:  2008-11-08       Impact factor: 3.159

10.  Type IV Ehlers-Danlos syndrome with platelet delta-storage pool disease.

Authors:  I Español; A Hernández; R M Pujol; T Urrutia; N Pujol-Moix
Journal:  Ann Hematol       Date:  1998 Jul-Aug       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.